Le Mans, 80 Players, 10 Countries: Therapeutic Table Tennis Is Building Its Own System

Fifth game. The scoreboard reads 3-10. Rob Cook, the English player from Leeds ParkyPING!, steps up to serve. He claws back to 8-10, then loses 3-2 to Wilco Jupil of France. The same day, in the men's doubles final, Cook partners a Dutch player and falls 3-1 to the Spanish pair Alonso - Lobarinas. Nigel Tarling of Brighton TTC, paired with a German teammate, loses a tight final to Gallon and Lacassagne. Two English players, two men's doubles silvers in Le Mans.

I read that results sheet more slowly than usual. For an analyst, the interesting part lies in how those two silvers were obtained.

The second PingPongParkinson French Open took place in Le Mans, drawing more than 80 players from 10 countries. This event sits outside the ITTF and WTT systems: no ranking points, no prize money, no Olympic pathway. In exchange, the organisers split the draw by C1, C2 and C3 classes, ran both singles and doubles, and built a consolation bracket for early losers. The participants are players living with Parkinson's, a condition that directly affects tremor, movement initiation speed and balance.

Table Tennis England reported on the event, and the Parkinson's England Table Tennis support network stands behind it. The medical rationale is stated clearly: table tennis is recognised as helping slow Parkinson's symptoms. From a systems perspective, this is an event tier that the familiar hierarchy of professional table tennis cannot measure.

The gap is not on the diagram; it sits between people.

What made me stop was the phrase scratch pairing — pairs assembled on site.

At the elite level, a table tennis doubles pair takes months to build. A left-hander partners a right-hander to close the middle of the table. Two playing styles must offset each other: one loops heavy topspin, the other blocks flat. Signals before every serve are read through the shoulder, through footwork rhythm, through a single nod.

In Le Mans, every one of those variables is neutralised by design. No shared practice sessions. No established chemistry. The test therefore shifts to two other capacities: adapting within days, and cooperating with someone just met.

The core finding of the whole event sits here: the tournament does not remove doubles chemistry, it turns doubles chemistry into something that must be manufactured on the spot. A structure like that completely reverses the weighting of doubles — away from rehearsed technique and toward the speed of reading a partner.

Both Tarling and Cook took silver with foreign partners. That result does not establish English superiority over Dutch or Spanish players. It shows both men handled a rapid communication problem between two people who share no language and, more importantly, share no competitive history.

The data point I keep returning to is Cook's recovery sequence. Down 0-2, then falling to 3-10 in the deciding game, he pulled back to 8-10. For an able-bodied player, that is a story about nerve. For someone living with Parkinson's — tremor, slow initiation, fluctuating balance — preserving shot quality across a run of points like that is data about sustaining motor control under pressure. It is not measured in inspiration; it is measured in points where the ball still found the table.

The gap is not on the diagram; it sits between people. Here, that gap is the interval between the handshake and the moment two players must understand each other.

The blind spot lies in how we read a silver medal.

Apply elite criteria and the questions become: what technique won it, what adjustment lost it. At this event tier, the decisive variable is classification. The C1, C2 and C3 classes function the way playing style does at the top: they guarantee that two people with comparable motor impairment meet each other. The classification criteria have not been published in detail, and that is an opacity worth tracking in future editions.

The second blind spot concerns the medical claim. The statement that table tennis slows Parkinson's symptoms carries the heaviest weight in the entire story, yet the source provides no specific research citation. I have read too many sport-for-health articles repeating that line as a mantra. It deserves verification through a controlled trial.

The third blind spot is sustainability. No ranking points and no prize money mean participation motivation is purely intrinsic. That model works at a scale of 80 people thanks to volunteers and national association backing, but it does not scale itself through revenue.

Based on my experience following these matches, I will verify three things next season: whether the C1-C3 criteria are published transparently; whether the third edition's country count moves past 10; and whether any Asian player appears on the entry list.

The gap is not on the diagram; it sits between people. And the largest gap in therapeutic table tennis right now sits between a movement growing fast and a data system that has not caught up with it.